Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Novozymes A/S, commonly referred to as Novozymes, is a leading Danish biotechnology company headquartered in Bagsværd, Denmark. Specialising in the chemicals nec industry, the company focuses on developing innovative enzyme and microbial solutions that enhance sustainability across various sectors. With a global presence spanning Europe, North America, and Asia, Novozymes serves diverse markets including agriculture, bioenergy, and household care.
Founded in 1925, Novozymes has established itself as a pioneer in industrial biotechnology, achieving numerous milestones in enzyme research and development. Its core products are distinguished by their ability to improve efficiency and reduce environmental impact, setting it apart in the chemicals nec industry. Recognised for its market leadership and commitment to sustainability, Novozymes continues to drive advancements in biological solutions worldwide.
+61 vs industry average
Novozymes’s score of 93 is higher than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Chemicals is among the most carbon-intensive industries
The Chemicals industry has reduced its overall emissions by 19% since 2018
Scope 3 accounts for ••• of total emissions.
Novozymes, a Chemicals nec company based in Denmark, reported total carbon emissions of approximately 1.35 billion kg CO2e in 2025. This includes 106.9 million kg CO2e from Scope 1 emissions, 52.4 million kg CO2e from Scope 2 market-based emissions, and approximately 1.19 billion kg CO2e from Scope 3 emissions. Notably, Scope 3 emissions were largely driven by purchased goods and services (1.00 billion kg CO2e) and upstream transportation and distribution (113.9 million kg CO2e).
Looking back, Novozymes's total emissions were approximately 1.38 billion kg CO2e in 2024, approximately 787 million kg CO2e in 2023, and approximately 895 million kg CO2e in 2022.
Novozymes is committed to ambitious climate action with several Science Based Targets initiative (SBTi) validated targets. The company aims to achieve net-zero greenhouse gas (GHG) emissions across its value chain by 2050, from a 2018 base year.
Near-term targets include:
Long-term targets include:
These targets are cascaded from Novonesis A/S (SBTi source).
2050
90% reduction in Scope 2
Novozymes A/S commits to reduce absolute scope 2 GHG emissions 90% by 2050 from a 2018 base year.
2030
75% reduction in Scope 2
Novozymes A/S commits to reduce absolute scope 2 GHG emissions 75% by 2030 from a 2018 base year.
2050
90% reduction in scope 3 total
Novozymes A/S commits to reduce absolute scope 3 GHG emissions from purchased goods and services, fuel and energy related activities, upstre…
See all 7 climate goals
Already have an account? Sign in now
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
See all scope 3 categories
Already have an account? Sign in now


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Common questions about Novozymes’s sustainability data and climate commitments
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more